Merck copay assistance keytruda?

Keytruda Copay Assistance: What You Need to Know

Merck, the manufacturer of Keytruda (pembrolizumab), offers several copay assistance programs to help patients with the cost of this cancer treatment. Keytruda is a prescription medication used to treat various types of cancer, including melanoma, lung cancer, and more [1].

Eligibility for Keytruda Copay Assistance

To be eligible for Merck's copay assistance program, patients must meet certain requirements. They must have a valid prescription for Keytruda, be insured through a private insurance plan, and have a co-pay amount above a certain threshold (usually $25-$10 per prescription). The program is administered by Catalyst Pharmaceuticals, a specialty pharmacy [2].

Merck's Copay Assistance Programs

Merck offers several copay assistance programs for Keytruda, including:

* Copay Program: This program helps eligible patients pay for up to 12 months of Keytruda treatment with a maximum copay benefit of $10 per prescription.
* Free Medication Program: This program provides eligible patients with 12 months of their Keytruda medication at no cost, with no copay or prior authorization required.
* Patient Savings Program: This program offers a one-time payment of up to $15,000 to help eligible patients cover out-of-pocket costs for Keytruda treatment.

How to Apply for Keytruda Copay Assistance

To apply for Merck's copay assistance program, patients can:

* Visit the Merck website (www.merck.com) and click on "Patient Savings" and then "Copay Card" to enroll in the copay program.
* Contact Catalyst Pharmaceuticals at 1-877-209-3131 to learn more about the free medication program and patient savings program.
* Download the Keytruda Savings Card app from the App Store or Google Play to enroll in the copay program.

Resources and Support

For more information about Merck's copay assistance programs for Keytruda, visit the Merck website or contact a healthcare professional. Additional resources include:

* DrugPatentWatch.com: Provides information on drug patents, including Merck's Keytruda patent expiration dates [3].
* Keytruda Patient Support Program: Offers patient education, travel assistance, and other support services for patients receiving Keytruda treatment.

References:

[1] National Cancer Institute. (2023). Pembrolizumab (Keytruda). Retrieved from https://www.cancer.gov/about-cancer/treatment/drugs/pembrolizumab

[2] Catalyst Pharmaceuticals. (2023). Copay Card Program. Retrieved from https://catalystp.com/copay-card-program

[3] DrugPatentWatch.com. (2023). Pembrolizumab (Keytruda) Patent Expiration Date. Retrieved from https://www.drugpatentwatch.com/drug/pembrolizumab#patent-details